Discover

HR
Healthcare Realty Trust Incorporated
17.19
8000 x 17.16
4800 x 17.14
bid
ask
+
0.31
1.84%
6400 @ 04:00 PM
17.19 +0.00 (0.00%)
Ytd1.42%
1y-2.77%
16.83
day range
17.23
16.31
52 week range
22.04
Open16.90Prev Close16.88Low16.83High17.23Mkt Cap6.03B
Vol7.92MAvg Vol3.84MEPS-0.26P/EN/AForward P/E245.36
Beta0.84Short Ratio5.29Inst. Own115.34%Dividend0.96Div Yield5.63
Ex Div Date08-11Earning10-2950-d Avg18.98200-d Avg18.791yr Est21.42

HR News

Healthcare Realty Trust Announces Third Quarter Earnings Release Date and Conference Call
globenewswire.com
Healthcare Realty Trust Announces Third Quarter Earnings Release Date and Conference Call

NASHVILLE, Tenn., Oct. 05, 2026 (GLOBE NEWSWIRE) -- Healthcare Realty Trust Incorporated (NYSE:HR) t

Pensionfund PDN Acquires 59,719 Shares of Healthcare Realty Trust Incorporated $HR
defenseworld.net
Pensionfund PDN Acquires 59,719 Shares of Healthcare Realty Trust Incorporated $HR

Pensionfund PDN acquired a new position in Healthcare Realty Trust Incorporated (NYSE: HR) during th

Corient Private Wealth LP Purchases 30,584 Shares of Healthcare Realty Trust Incorporated $HR
defenseworld.net
Corient Private Wealth LP Purchases 30,584 Shares of Healthcare Realty Trust Incorporated $HR

Corient Private Wealth LP bought a new stake in Healthcare Realty Trust Incorporated (NYSE: HR) in t

State Street Corp Reduces Stock Position in Healthcare Realty Trust Incorporated $HR
defenseworld.net
State Street Corp Reduces Stock Position in Healthcare Realty Trust Incorporated $HR

State Street Corp trimmed its stake in shares of Healthcare Realty Trust Incorporated (NYSE: HR) by

Down 5.8% in 4 Weeks, Here's Why You Should You Buy the Dip in Healthcare Realty Trust (HR)
zacks.com
Down 5.8% in 4 Weeks, Here's Why You Should You Buy the Dip in Healthcare Realty Trust (HR)

The heavy selling pressure might have exhausted for Healthcare Realty Trust (HR) as it is technicall

PureTech Announces Successful End-of-Phase 1 Meeting with U.S. Food and Drug Administration (FDA) and Receipt of Fast Track Designation for LYT-200 in Relapsed/Refractory (R/R) High-Risk Myelodysplast
gurufocus.com
PureTech Announces Successful End-of-Phase 1 Meeting with U.S. Food and Drug Administration (FDA) an

[url="]PureTech Health plc[/url] (LSE: PRTC) ("PureTech" or the "Company"), a hub-and-spoke biothera

benzinga.com
Jefferies Assumes Healthcare Realty Trust at Hold, Lowers Price Target of $20

Jefferies analyst Joe Dickstein assumes Healthcare Realty Trust (NYSE:HR) with a Hold rating and

ENHERTU® (fam-trastuzumab deruxtecan-nxki) demonstrated a median progression-free survival of 14.3 months as 1st-line therapy in patients with HER2-mutant advanced non-small cell lung cancer in DESTIN
gurufocus.com
ENHERTU® (fam-trastuzumab deruxtecan-nxki) demonstrated a median progression-free survival of 14.3 m

Positive results from the DESTINY-Lung04 Phase III trial showed AstraZeneca and Daiichi Sankyo's ENH

Ivonescimab Monotherapy Demonstrates a Statistically Significant & Clinically Meaningful Benefit Compared to Pembrolizumab Monotherapy in PD-L1-Positive Advanced NSCLC in Akeso's HARMONi-2 Study Condu
gurufocus.com
Ivonescimab Monotherapy Demonstrates a Statistically Significant & Clinically Meaningful Benefit Com

Summit Therapeutics Inc. (NASDAQ: SMMT) today noted that its partner Akeso Inc. [url="]announced[/ur

Healthcare Realty Trust (HR) Upgraded to Buy: What Does It Mean for the Stock?
zacks.com
Healthcare Realty Trust (HR) Upgraded to Buy: What Does It Mean for the Stock?

Healthcare Realty Trust (HR) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism

ETCAMAH® (camizestrant) in combination with a CDK4/6 inhibitor approved in the US for 1st-line advanced HR-positive breast cancer
gurufocus.com
ETCAMAH® (camizestrant) in combination with a CDK4/6 inhibitor approved in the US for 1st-line advan

AstraZeneca's ETCAMAHÂ (camizestrant) in combination with a cyclin-dependent kinase (CDK) 4/6 inhibi

benzinga.com
Wells Fargo Maintains Equal-Weight on Healthcare Realty Trust, Lowers Price Target to $20

Wells Fargo analyst John Kilichowski maintains Healthcare Realty Trust (NYSE:HR) with a Equal-Wei

Bears are Losing Control Over Healthcare Realty Trust (HR), Here's Why It's a 'Buy' Now
zacks.com
Bears are Losing Control Over Healthcare Realty Trust (HR), Here's Why It's a 'Buy' Now

Healthcare Realty Trust (HR) appears to have found support after losing some value lately, as indica

After Plunging 7.0% in 4 Weeks, Here's Why the Trend Might Reverse for Healthcare Realty Trust (HR)
zacks.com
After Plunging 7.0% in 4 Weeks, Here's Why the Trend Might Reverse for Healthcare Realty Trust (HR)

Healthcare Realty Trust (HR) has become technically an oversold stock now, which implies exhaustion

benzinga.com
RBC Capital Maintains Sector Perform on Healthcare Realty Trust, Raises Price Target to $22

RBC Capital analyst Michael Carroll maintains Healthcare Realty Trust (NYSE:HR) with a Sector Per

Healthcare Realty Trust Q2 Earnings Call Highlights
marketbeat.com
Healthcare Realty Trust Q2 Earnings Call Highlights

Healthcare Realty Trust NYSE: HR reported second-quarter results marked by higher occupancy, leasing

Healthcare Realty Trust Incorporated (HR) Q2 2026 Earnings Call Transcript
seekingalpha.com
Healthcare Realty Trust Incorporated (HR) Q2 2026 Earnings Call Transcript

Healthcare Realty Trust Incorporated (HR) Q2 2026 Earnings Call Transcript

benzinga.com
Cantor Fitzgerald Maintains Overweight on Healthcare Realty Trust, Raises Price Target to $24

Cantor Fitzgerald analyst Richard Anderson maintains Healthcare Realty Trust (NYSE:HR) with a Ove

Healthcare Realty Trust (HR) Q2 FFO and Revenues Beat Estimates
zacks.com
Healthcare Realty Trust (HR) Q2 FFO and Revenues Beat Estimates

Healthcare Realty Trust (HR) came out with quarterly funds from operations (FFO) of $0.41 per share,

benzinga.com
Healthcare Realty Trust Q2 FFO $0.41 Beats $0.40 Estimate, Sales $281.849M Beat $274.580M Estimate

Healthcare Realty Trust (NYSE:HR) reported quarterly earnings of $0.41 per share which beat the anal

benzinga.com
Healthcare Realty Trust Raises FY2026 FFO Guidance from $1.59-$1.65 to $1.62-$1.66 vs $1.62 Est

Healthcare Realty Trust (NYSE:HR) raises FY2026 FFO guidance from $1.59-$1.65 to $1.62-$1.66 vs $1.6

Healthcare Realty Reports Second Quarter 2026 Results and Further Increases Full Year 2026 Guidance
globenewswire.com
Healthcare Realty Reports Second Quarter 2026 Results and Further Increases Full Year 2026 Guidance

NASHVILLE, Tenn., July 30, 2026 (GLOBE NEWSWIRE) -- Healthcare Realty Trust Incorporated (NYSE:HR) t

benzinga.com
JP Morgan Maintains Neutral on Healthcare Realty Trust, Raises Price Target to $21

JP Morgan analyst Michael Mueller maintains Healthcare Realty Trust (NYSE:HR) with a Neutral and

Healthcare Realty Trust Announces Second Quarter Earnings Release Date and Conference Call
globenewswire.com
Healthcare Realty Trust Announces Second Quarter Earnings Release Date and Conference Call

NASHVILLE, Tenn., July 07, 2026 (GLOBE NEWSWIRE) -- Healthcare Realty Trust Incorporated (NYSE:HR) t

benzinga.com
Raymond James Reinstates Outperform on Healthcare Realty Trust, Announces $24 Price Target

Raymond James analyst David Rodgers reinstates Healthcare Realty Trust (NYSE:HR) with a Outperfor

enGene Reports Second Quarter 2026 Financial Results and Provides Business Update
gurufocus.com
enGene Reports Second Quarter 2026 Financial Results and Provides Business Update

enGene Therapeutics Inc. (Nasdaq: ENGN, “enGene” or the “Company”), a clinical-stage, non-vi

New Strong Buy Stocks for June 8th
zacks.com
New Strong Buy Stocks for June 8th

EXPD, VNCE, UCTT, PRG and TNET have been added to the Zacks Rank #1 (Strong Buy) List on June 8, 202

Camizestrant Combination Delayed Time to First Progression by 55% and to Second Progression by 37% in Patients With Advanced HR-positive Breast Cancer With an Emergent ESR1 Tumor Mutation in SERENA-6
gurufocus.com
Camizestrant Combination Delayed Time to First Progression by 55% and to Second Progression by 37% i

Further positive results from the Phase III SERENA-6 trial showed AstraZeneca's camizestrant plus a

benzinga.com
Wells Fargo Maintains Equal-Weight on Healthcare Realty Trust, Raises Price Target to $21

Wells Fargo analyst John Kilichowski maintains Healthcare Realty Trust (NYSE:HR) with a Equal-Wei

benzinga.com
RBC Capital Maintains Sector Perform on Healthcare Realty Trust, Raises Price Target to $21

RBC Capital analyst Michael Carroll maintains Healthcare Realty Trust (NYSE:HR) with a Sector Per

benzinga.com
Scotiabank Maintains Sector Outperform on Healthcare Realty Trust, Raises Price Target to $22

Scotiabank analyst Nicholas Yulico maintains Healthcare Realty Trust (NYSE:HR) with a Sector Outp

benzinga.com
Citigroup Maintains Neutral on Healthcare Realty Trust, Raises Price Target to $21

Citigroup analyst Nick Joseph maintains Healthcare Realty Trust (NYSE:HR) with a Neutral and rais

benzinga.com
Cantor Fitzgerald Maintains Overweight on Healthcare Realty Trust, Raises Price Target to $22

Cantor Fitzgerald analyst Richard Anderson maintains Healthcare Realty Trust (NYSE:HR) with a Ove

benzinga.com
Healthcare Realty Plans $500M Notes Offering to Refinance Debt and Strengthen Balance Sheet

Healthcare Realty Trust Incorporated (NYSE:HR) ("Healthcare Realty") today announced that it

Transcript: Healthcare Realty Trust Q1 2026 Earnings Conference Call
benzinga.com
Transcript: Healthcare Realty Trust Q1 2026 Earnings Conference Call

benzinga.com
Healthcare Realty Trust Raises FY2026 FFO Guidance from $1.58-$1.64 to $1.59-$1.65 vs $0.23 Est

Healthcare Realty Trust (NYSE:HR) raises FY2026 FFO guidance from $1.58-$1.64 to $1.59-$1.65 vs $0.2

benzinga.com
Healthcare Realty Trust Q1 FFO $0.41. Sales $278.990M Miss $281.600M Estimate

Healthcare Realty Trust (NYSE:HR) reported quarterly earnings of $0.41 per share. This is a 5.13 per

Earnings Scheduled For April 30, 2026
benzinga.com
Earnings Scheduled For April 30, 2026

benzinga.com
UBS Initiates Coverage On Healthcare Realty Trust with Neutral Rating, Announces Price Target of $18

UBS initiates coverage on Healthcare Realty Trust (NYSE:HR) with a Neutral rating and announces Pr

benzinga.com
Cantor Fitzgerald Maintains Overweight on Healthcare Realty Trust, Raises Price Target to $21

Cantor Fitzgerald analyst Richard Anderson maintains Healthcare Realty Trust (NYSE:HR) with a Ove

benzinga.com
Healthcare Realty Trust Q4 FFO $0.40, Same YoY, Sales $286.303M Beat $286.152M Estimate

Healthcare Realty Trust (NYSE:HR) reported quarterly earnings of $0.40 per share. This is unchanged

Earnings Scheduled For February 12, 2026
benzinga.com
Earnings Scheduled For February 12, 2026

benzinga.com
Healthcare Realty Trust Appoints Daniel Gabbay CFO, Effective Jan. 12, Succeeding Austen Helfrich

Healthcare Realty Trust Incorporated (NYSE:HR) ("Healthcare Realty" or the "Company"

benzinga.com
Wells Fargo Maintains Equal-Weight on Healthcare Realty Trust, Raises Price Target to $19

Wells Fargo analyst John Kilichowski maintains Healthcare Realty Trust (NYSE:HR) with a Equal-Wei

benzinga.com
Healthcare Realty Trust Q3 FFO $0.41, Sales $297.765M Beat $292.388M Estimate

Healthcare Realty Trust (NYSE:HR) reported quarterly sales of $297.765 million which beat the analys

Earnings Scheduled For October 30, 2025
benzinga.com
Earnings Scheduled For October 30, 2025

Alphabet To Rally More Than 10%? Here Are 10 Top Analyst Forecasts For Monday
benzinga.com
Alphabet To Rally More Than 10%? Here Are 10 Top Analyst Forecasts For Monday

benzinga.com
What 8 Analyst Ratings Have To Say About Healthcare Realty Trust

benzinga.com
Wells Fargo Upgrades Healthcare Realty Trust to Equal-Weight, Raises Price Target to $18

Wells Fargo analyst John Kilichowski upgrades Healthcare Realty Trust (NYSE:HR) from Underweight

This W.W. Grainger Analyst Begins Coverage On A Bearish Note; Here Are Top 5 Initiations For Wednesday
benzinga.com
This W.W. Grainger Analyst Begins Coverage On A Bearish Note; Here Are Top 5 Initiations For Wednesd